Abstract
Increased blood serotonin in people with autism was first reported over 50 years ago, and this biogenic amine has remained a focus for the understanding, risk and treatment of Autism Spectrum Disorders (ASD). There is growing evidence that serotonergic transmission is altered by disparate genetic and environmental risk factors for ASD. This review will focus on recent developments regarding serotonin in ASD. Recent studies include epidemiology studies linking ASD with conditions that alter prenatal serotonin in the fetus, altered serotonin in diverse genetic and environmental animal models, and human pathology and molecular and functional brain imaging studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson GM, Freedman DX, Cohen DJ, Volkmar FR, Hoder EL, McPhedran P, Minderaa RB, Hansen CR, Young JG (1987) Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 28:885–900
Anderson GM, Hertzig ME, McBride PA (2012) Brief report: platelet-poor plasma serotonin in autism. J Autism Dev Disord 42:1510–1514
Azmitia EC, Singh JS, Whitaker-Azmitia PM (2011a) Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors. Neuropharmacology 60:1347–1354
Azmitia EC, Singh JS, Hou XP, Wegiel J (2011b) Dystrophic serotonin axons in postmortem brains from young autism patients. Anat Rec, 294:1653–1662
Balkovetz DF, Tiruppathi C, Leibach FH, Mahesh VB, Ganapathy V (1989) Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes. J Biol Chem 264:2195–2198
Berger M, Gray JA, Roth BL (2009) The expanded biology of serotonin. Annu Rev Med 60:355–366.
Berman NEJ, Puri V, Chandrala S, Puri S, Macgregor R, Liverman CS, Klein RM (2006) Serotonin in trigeminal ganglia of female rodents: relevance to menstrual migraine. Headache 46:1230–1245
Beversdorf DQ, Nordgren RE, Bonab AA, Fischman AJ, Weise SB, Dougherty DD, Felopulos GJ, Zhou FC, Bauman ML (2012) 5-HT2 receptor distribution shown by [18F]setoperone PET in high-functioning autistic adults. J Neuropsychiatry Clin Neurosci 24:191–197
Bonnin A, Goeden N, Chen K, Wilson ML, King J, Shih JC, Blakely RD, Deneris ES, Levitt P (2011) A transient placental source of serotonin for the fetal forebrain. Nature 472:347–350
Bortolato M, Chen K, Shih JC (2008) Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev 60:1527–1533
Brodkin ES (2007) BALB/c mice: low sociability and other phenotypes that may be relevant to autism. Behav Brain Res 176:53–65
Bromley RL, Mawer GE, Briggs M, Cheyne F, Clayton-Smith J, GarcÃa-Fiñana M, Kneen R, Lucas SB, Shallcross R, Baker GA; Liverpool and Manchester Neurodevelopment Group (2013) The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 84:637–643
Cassel S, Carouge D, Gensburger C, Anglard P, Burgun C, Dietrichm JB, Aunis D, Zwiller J (2006) Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 70:487–492
Chandana SR, Behen ME, Juhasz C, Muzik O, Rothermel RD, Mangner TJ, Chakraborty PK, Chugani HT, Chugani DC (2005) Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int J Dev Neurosci 23:171–182
Chantiluke K, Barrett N, Giampietro V, Brammer M, Simmons A, Murphy DG, Rubia K (2014) Inverse effect of fluoxetine on medial prefrontal cortex activation during reward reversal in ADHD and autism. Cereb Cortex [Epub ahead of print]
Chess S (1971) Autism in children with congenital rubella. Journal of Autism and Childhood Schizophrenia 1:33–47
Christenson JG, Dairman W, Udenfriend S (1972) On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine). Proc Nat Acad Sci U S A 69:343–347
Christensen J, Grønborg TK, Sørensen MJ, Schendel D, Parner ET, Pedersen LH, Vestergaard M (2013) Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309:1696–1703
Chugani DC, Muzik O, Rothermel R, Behen M, Chakraborty P, Mangner T, da Silva EA, Chugani HT (1977) Altered serotonin synthesis in the dentatothalamo-cortical pathway in autistic boys. Ann Neurol 14:666–669
Chugani DC, Muzik O, Behen M, Rothermel R, Janisse JJ, Lee J, Chugani HT (1999) Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 45:287–295
Cohen IL, Liu X, Schutz C, White BN, Jenkins EC, Brown WT, Holden JJ (2003) Association of autism severity with a monoamine oxidase a functional polymorphism. Clin Genet 64:190–197
Cook EH Jr Charak DA Arida J Spohn JA Roizen NJ Leventhal BL (1994) Depressive and obsessive–compulsive symptoms in hyperserotonemic parents of children with autistic disorder. Psychiatry Res 52:25–33
Cook EH Jr, Lindgren V, Leventhal BL, Courchesne R, Lincoln A, Shulman C, Lord C, Courchesne E (1997) Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 60:928–934
Cook EH Jr Leventhal BL Heller W Metz J Wainwright M Freedman DX (1990) Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. J Neuropsychiatry Clin Neurosci 2:268–274
Coon H, Dunn D, Lainhart J, Miller J, Hamil C, Battaglia A, Tancredi R, Leppert MF, Weiss R, McMahon W (2005) Possible association between autism and variants in the brain-expressed tryptophan hydroxylase gene (TPH2). Am J Med Genet B Neuropsychiatr Genet 135B:42–46
Correa RR, Barrilari SE, Guimaraes CS, Rossi e Silva RC, Olegario JG, Cavellani CL, Oliveira FA, Salge AK, Teixeira VP, Castro EC (2009) Expression of the melatonin receptor and tryptophan hydroxylase in placentas of the fetus with intra-uterine stress. Eur J Obstet Gynecol Reprod Biol 147:234–236
Cote F, Fligny C, Bayard E, Launay JM, Gershon MD, Mallet J, Vodjdani G (2007) Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci U S A 104:329–334
Coutinho AM, Sousa I, Martins M, Correia C, Morgadinho T, Bento C, Marques C, AtaÃde A, Miguel TS, Moore, JH, Oliveira G, Vicente AM (2007) Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum Genet 121:243–256
Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V (2011) Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 68:1104–1112
Daly EM, Deeley Q, Ecker C, Craig M, Hallahan B, Murphy C, Johnston P, Spain D, Gillan N, Brammer M, Giampietro V, Lamar M, Page L, Toal F, Cleare A, Surguladze S, Murphy DG (2012) Serotonin and the neural processing of facial emotions in adults with autism: an fMRI study using acute tryptophan depletion. Arch Gen Psychiatry 69:1003–1013
Davis LK, Hazlett HC, Librant AL, Nopoulos P, Sheffield VC, Piven J, Wassink TH (2008) Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase a gene. Am J Med Genet B Neuropsychiatr Genet 147B:1145–1151
Devlin B, Cook EH Jr, Coon H, Dawson G, Grigorenko EL, McMahon W, Minshew N, Pauls D, Smith, M, Spence MA, Rodier PM, Stodgell C, Schellenberg GD (2005) CPEA Genetics Network Autism and the serotonin transporter, the long and short of it. Mol Psychiatry 10:1110–1116
Deykin EY, MacMahon B (1979) Viral exposure and autism. Am J Epidemiol 109:628–638
Diksic M, Nagahiro S, Sourkes TL, Yamamoto YL (1990) A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model. J Cereb Blood Flow Metab 9:1–12
Eddahibi S, Guignabert C, Barlier-Mur AM, Dewachter L, Fadel E, Dartevelle P, Humbaert M, Simonneau G, Hanoun N, Saurini F, Hamon M, Adnot S (2006) Cross talk between endothelial and smooth muscle cells in pulmonary hypertension. Circulation 113:1857–1864
Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S, Smee DF, Pearce DA, Winter C, Sohr R, Juckel G (2008) Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res 99:56–70
Fernstrom JD, Wurtman RJ (1971) Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 173:149–151
Gershon MD, Tack J (2007) The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132:397–414
Ghaziuddin M, Tsai LY, Eilers L, Ghaziuddin N (1992) Brief report: Autism and herpes simplex encephalitis. J Autism Dev Disord 22:107–113
Girgis RR, Slifstein M, Xu X, Frankle WG, Anagnostou E, Wasserman S, Pepa L, Kolevzon A, Abi-Dargham A, Laruelle M, Hollander E (2011) The 5-HT(2A) receptor and serotonin transporter in Asperger’s disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB. Psychiatry Res 194:230–234
Goldberg J, Anderson GM, Zwaigenbaum L, Hall GB, Nahmias C, Thompson A, Szatmari P (2009) Cortical serotonin type-2 receptor density in parents of children with autism spectrum disorders. J Autism Dev Disord 2009:97–104
Hagerman R, Hoem G, Hagerman P (2010) Fragile X and autism: Intertwined at the molecular level leading to targeted treatments. Mol Autism 1:12
Hamon M, Bourgoin S, Artaud FEl, Mestikawy S (1981) The respective roles of tryptophan uptake and tryptophan hydroxylase in the regulation of serotonin synthesis in the central nervous system. J Physiol 77:269–279
Hoshino Y, Yamamoto T, Kaneko M, Tachibana R, Watanabe M, Ono Y, Kumashiro H (1984) Blood serotonin and free tryptophan concentration in autistic children. Neuropsychobiol 11:22–27
Hviid A, Melbye M, Pasternak B (2013) Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med 369:2406–2415
Ide S, Itoh M, Goto Y (2005) Defect in normal developmental increase of the brain biogenic amine concentration in the mecp2-null mouse. Neurosci Lett 386:14–17
Ikeda K, Tojo K, Otsubo C, Udagawa T, Kumazawa K, Ishikawa M, Tokudome G, Hosoya T, Tajima N, Claycomb WC, Nakao K, Kawamura M (2005) 5-hydroxytryptamine synthesis in HL-1 cells and neonatal rat cardiocytes. Biochem Biophys Res Commun 328:522–525
Jones MB, Palmour RM, Zwaigenbaum L, Szatmari P (2004) Modifier effects in autism at the MAO-A and DBH loci. Am J Med Genet B Neuropsychiatr Genet 126:58–65
Kane MJ, Angoa-Peréz M, Briggs DI, Sykes CE, Francescutti DM, Rosenberg DR, Kuhn DM (2012) Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism. PLoS One 7:e48975
Kannan S, Saadani-Makki F, Muzik O, Chakraborty P, Mangner TJ, Janisse J, Romero R, Chugani DC (2007) Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and small-animal PET. J Nucl Med 48:946–954
Kannan S, Saadani-Makki F, Balakrishnan B, Dai H, Chakraborty PK, Janisse J, Muzik O, Romero R, Chugani DC (2011) Decreased cortical serotonin in neonatal rabbits exposed to endotoxin in utero. J Cereb Blood Flow Metab 31:738–749
Kerr TM, Muller CL, Miah M, Jetter CS, Pfeiffer R, Shah C, Baganz N, Anderson GM, Crawley JN, Sutcliffe JS, Blakely RD, Veenstra-Vanderweele J (2013) Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice. Mol Autism 4:35
Kim DK, Tolliver TJ, Huang S J, Martin BJ, Andrews AM, Wichems C, Holmes A, Lesch KP, Murphy DL (2005) Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacol 49:798–810
Kudo Y, Boyd CA (2002) Human placental amino acid transporter genes: expression and function. Reproduction 124:593–600
Leboyer M, Philippe A, Bouvard M, Guilloud-Bataille M, Bondoux D, Tabuteau F, Feingold J, Mouren-Simeoni MC, Launay JM (1999) Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol Psychiatry 45:158–163
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J Müller, CR Hamer DH, Murphy DL (1996) Association of anxiety-related with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527–1531
Leventhal BL, Cook Jr, EH, Morford M, Ravitz A, Freedman DX (1990) Relationships of whole blood serotonin and plasma norepinephrine within families. J Autism Dev Disord, 20:499–511
Ligam P, Manuelpillai U, Wallace EM, Walker D (2005) Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for role of the kynurenine pathway in pregnancy. Placenta 26:498–504
Lin HC, Gean PW, Wang CC, Chan YH, Chen PS (2013) The amygdala excitatory/inhibitory balance in a valproate-induced rat autism model. PLoS One 8:e55248
Mackler AM, Barber EM, Takikawa O, Pollard JW (2003) Indoleamine 2,3-dioxygenase is regulated by IFN-gamma in the mouse placenta during Listeria monocytogenes infection. J Immunol 170:823–830
Makkonen I, Riikonen R, Kokki H, Airaksinen MM, Kuikka JT (2008) Serotonin and dopamine transporter binding in children with autism determined by SPECT. Dev Med Child Neurol 50:593–597
Manuelpillai U, Ligam P, Smythe G, Wallace EM, Hirst J, Walker DW (2005) Identification of kynurenine pathway enzyme mRNAs and metabolites in human placenta: up-regulation by inflammatory stimuli and with clinical infection. Am J Obstet Gynecol 192:280–288
Mason-Brothers A, Ritvo ER, Pingree C, Petersen PB, Jenson WR, McMahon WM, Freeman BJ, Jorde LB, Spencer MJ, Mo A (1990) The UCLA-University of Utah epidemiologic survey of autism: prenatal, perinatal, and postnatal factors. Pediatrics 86:514–519
Matsuda M, Imaoka T, Vomachka AJ, Gudelsky GA, Hou Z, Mistry M, Bailey JP, Nieport KM, Walther DJ, Bader M, & Horseman ND (2004) Serotonin regulates mammary gland development via an autocrine–paracrine loop. Development Cell 6:193–203
Moja EA, Stoff DM, Gessa GL, Castoldi D, Assereto R, Tofanetti O (1988) Decrease in plasma tryptophan after tryptophan-free amino acid mixtures in man. Life Sci 42:1551–1556
Moja EA, Cipolla P, Castoldi D, Tofanetti O (1989) Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats. Life Sci 44:971–976
Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191–1193
Murphy DG, Daly E, Schmitz N, Toal F, Murphy K, Curran S, Erlandsson K, Eersels J, Kerwin R, Ell P, Travis M (2006) Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger’s syndrome: an in vivo SPECT study. Am J Psychiatry 163:934–936.
Nabi R, Serajee FJ, Chugani DC, Zhong H, Huq AH (2004) Association of tryptophan 2,3 dioxygenase gene polymorphism with autism. Am J Med Genet B Neuropsychiatr Genet 125:63–68
Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K, Matsuzaki H, Suda S, Sugiyama T, Takei N, Mori N (2010) Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry 67:59–68
Ni W, Watts SW (2006) 5-hydroxytryptamine in the cardiovascular systems: focus on the serotonin transporter (SERT). Clin Exp Pharmacol Physiol 33:575–583
Ni W, Geddes TJ, Priestley JR, Szasz T, Kuhn DM, Watts SW (2008) The existence of a local 5-hydroxytryptaminergic system in peripheral arteries. Br J Pharmacol 154:663–674
Nocito A, Dahm F, Jochum W, Jang JH, Georgiev P, Bader M, Renner EL, Clavien PA (2007) Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Gastroenterology 133:608–618
Oblak A, Gibbs TT, Blatt GJ (2013) Reduced serotonin receptor subtypes in a limbic and a neocortical region in autism. Autism Res 6:571–583
Oritz-Alvarado R, Guzmán-Quevedo O, Meracado-Camargo R, Haertle T, Vignes C, Bolaños-Jiménez F (2006) Expression of tryptophan hydroxylase in developing mouse taste papillae. FEBS Letters 580:5371–5376
Pardridge, WM (1977) Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J Neurochem 28:103–108
Patterson PH (2009) Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 204:313–321
Piven J, Tsai GC, Nehme E, Coyle JT, Chase GA, Folstein SE (1991) Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord 21:51–59
Sakowski SA, Geddes TJ, Thomas DM, Levi E, Hatfield JS, Kuhn DM (2006) Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies. Brain Res 1085:11–18
Samaco RC, Mandel-Brehm C, Chao HT, Ward CS, Fyffe-Maricich SL, Ren J, Hyland K, Thaller C, Maricich SM, Humphreys P, Greer JJ, Percy A, Glaze DG, Zoghbi HY, Neul JL (2009) Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci U S A 106:21966–21971
Schain RJ, Freedman DX (1961) Studies on 5-hydroxyindole metabolism in autism and other mentally retarded children. J Pediatr 59:315–320
Siesser WB, Zhang X, Jacobsen JP, Sotnikova TD, Gainetdinov RR, Caron MG (2010) Tryptophan hydroxylase 2 genotype determines brain serotonin synthesis but not tissue content in C57Bl/6 and BALB/c congenic mice. Neurosci Lett 481:6–11
Slominski A, Pisarchik A, Semak I, Sweatman T, Worstman J, Szczesniewski A, Slugocki G, McNulty J, Kauser S, Tobin DJ (2002) Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J 16:896–898
Smith QR, Monna S, Aoyagi M, & Rapoport SI (1987) Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 49:1651–1658
Smit-Rigter LA, Noorlander CW, von Oerthel L, Chameau P, Smidt MP, van Hooft JA (2012) Prenatal fluoxetine exposure induces life-long serotonin 5-HT3 receptor-dependent cortical abnormalities and anxiety-like behaviour. Neuropharmacology 62:865–870
Stone TW (2001) Endogenous neurotoxins from tryptophan. Toxicon 39:61–73
Stull MA, Pai V, Vomachka AJ, Marshall AM, Joacb GA, Horseman ND (2007) Mammary gland homeostasis employs serotonergic regulation of epithelial tight junctions. Proc Natl Acad Sci 104:16708–16713
Tamada K, Tomonaga S, Hatanaka F, Nakai N, Takao K, Miyakawa T, Nakatani J, Takumi T (2010) Decreased exploratory activity in a mouse model of 15q duplication syndrome; implications for disturbance of serotonin signaling. PLoS One 5e:15126
Tassone F, Qi L, Zhang W, Hansen RL, Pessah IN, Hertz-Picciotto I (2011) MAOA, DBH and SLC6A4 variants in CHARGE: A case control study of autism spectrum disorders. Autism Res 4:250–261
Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57:67–81
Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, Owens WA, Shah CR, Cohen J, Mannangatti P, Jessen T, Thompson BJ, Ye R, Kerr TM, Carneiro AM, Crawley JN, Sanders-Bush E, McMahon DG, Ramamoorthy S, Daws LC, Sutcliffe JS, Blakely RD (2012) Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A 109:5469–5474
Verma D, Chakraborti B, Karmakar A, Bandyopadhyay T, Singh AS, Sinha S, Chatterjee A, Ghosh S, Mohanakumar KP, Mukhopadhyay K, Rajamma U (2013) Sexual dimorphic effect in the genetic association of monoamine oxidase A (MAOA) markers with autism spectrum disorder. Prog Neuropsychopharmacol Biol Psychiatry 50C:11–20
Walther DJ, Peter JU, Winter S, Höltje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, Bader M (2003) Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 115:851–862
Walther DJ, Stahlberg S, Vowinckel J (2011) Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases. FEBS J 278:4740–4755
Wang CC, Lin HC, Chan YH, Gean PW, Yang YK, Chen PS (2013) 5-HT1A-receptor agonist modified amygdala activity and amygdala-associated social behavior in a valproate-induced rat autism model. Int J Neuropsychopharmacol 16:2027–2039
Wassink TH, Hazlett HC, Epping EA, Arndt S, Dager SR, Schellenberg GD, Dawson, G, Piven J (2007) Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch Gen Psychiatry 64:709–717
Weiss LA, Ober C, Cook EH Jr (2006a) ITGB3 shows genetic and expression interaction with SLC6A4. Hum Genet 120:93–100
Weiss LA, Kosova G, Delahanty RJ, Jiang L, Cook EH, Ober C, Sutcliffe JS (2006b) Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility. Eur J Hum Genet 14:923–931
Whyte A, Jessen T, Varney S, Carneiro AM (2014) Serotonin transporter and integrin beta 3 genes interact to modulate serotonin uptake in mouse brain. Neurochem Int 73:122–126
Winter C, Reutiman TJ, Folsom TD, Sohr R, Wolf RJ, Juckel G, Fatemi SH (2008) Dopamine and serotonin levels following prenatal viral infection in mouse—implications for psychiatric disorders such as schizophrenia and autism. Eur Neuropsychopharmacol 18:712–716
Yamashita, Y, Fujimoto, C, Nakajima E, Isagai, T, Matsuishi, T (2003) Possible association between congenital cytomegalovirus infection and autistic disorder. J Autism Dev Disord 33:455–459
Zerbo O, Qian Y, Yoshida C, Grether JK, Van de Water J, Croen LA (2013) Maternal infection during pregnancy and autism spectrum disorders. J Autism Dev Disord [Epub ahead of print]
Zhang X, Beaulieu, JM, Sotnikova TD, Gainetdinov RR, Caron MG (2004) Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305:217
Zhang YQ, Friedman DB, Wang Z, Woodruff E 3rd, Pan L, O’Donnell J, Broadie K (2005) Protein expression profiling of the drosophila fragile X mutant brain reveals up-regulation of monoamine synthesis. Mol Cell Proteomics 4:278–290
Zhao X, Leotta A, Kustanovich V, Lajonchere C, Geschwind DH, Law K, Law P, Qiu S, Lord C, Sebat, J, Ye K, Wigler M (2007) A unified genetic theory for sporadic and inherited autism. Proc Nat Acad Sci U S A 104:12831–12836
Zoghbi HY, Milstien S, Butler IJ, Smith EO, Kaufman S, Glaze DG, Percy AK (1989) Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome. Ann Neurol 25:56–60
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Benza, N., Chugani, D. (2015). Serotonin in Autism Spectrum Disorder: Insights from Human Studies and Animal Models. In: Fatemi, S. (eds) The Molecular Basis of Autism. Contemporary Clinical Neuroscience. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2190-4_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2190-4_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2189-8
Online ISBN: 978-1-4939-2190-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)